Document is current
Any future updates will be listed below
-
Authors
Keßler, Franziska
Oelkrug, Franziska
Oberlechner, Ernst
Andress, Jürgen
Brucker, Sara Y.
Koch, André
Berrio, Daniel A. Carvajal
Schenke-Layland, Katja
Weiss, Martin
-
Funding
Funding for this research was provided by:
German Research Foundation (GRK 2543/1)
German Research Foundation (INST 2388/341 and INST 2388/641)
Martin Weiss, Faculty of Medicine of the Eberhard Karls University Tübingen (IZKF 2018106)
Faculty of Medicine of the Eberhard Karls University Tübingen (243210 and 41700)
Deutsche Forschungsgemeinschaft (GRK 2543/1)
- License Information
-
More Information
Article History
Received: 24 April 2026
Accepted: 1 September 2026
First Online: 29 September 2026
Declarations
Informed consent: Written informed consent was obtained from the patients for the collection and scientific use of ascites-derived cells in this study.
Institutional review board statement: Primary human ovarian cancer cells were isolated from ascites obtained from consenting patients undergoing surgery at the Department of Women’s Health, University Hospital Tübingen. The scientific use of the tissue was approved by the Ethical Committee of the Medical Faculty of the Eberhard Karls University of Tübingen (approval numbers: 6492017BO2, approved 12 January 2018; 495/2018BO2, approved 19 October 2018).
Competing interests: The authors declare no competing interests.
